Kristina M. Thurber, Pharm D., R.PH., specializes in obesity pharmacotherapy management at Mayo Clinic. In this discussion, she highlights the alarming obesity epidemic in the U.S. and the role of GLP-1 agonists in weight loss and diabetes management. Kristina explains how these medications work, their potential impact on weight loss expectations, and economic challenges facing patients. She also advocates for a holistic approach to obesity management, combining medication with lifestyle changes and emphasizes the importance of communication in patient care.
